Christmas and New Year clinic closure and shipping dates
Orders placed before 23:59 on Sunday 24th of December will be shipped within the year (JST).
Any orders placed after that will be shipped from Friday the 5th of January accordingly.
Best wishes from all of us for the Holiday Season.


Doctor Presentations

Conference presentation - Sep 2016 at Sydney -

Dr. Toshio Inui did a presentation about Clinical application of Second Generotaion GcMAF and oral MAF at Sydney on 24th Sep.

Conference presentation - July 2016 at Jakarta -

Dr. Toshio Inui did a presentation about Saisei Mirai at Jakarta on 21st July.

Conference presentation - International Pharmacy Conference, July 2016 -

Dr. Shinichiro Akiyama did the presentaion of "Clinical experience of colostrum derived protein against solid cancer" in the Interenational Pharmacy Conference (July 14-15, 2016) Philadelphia, PA, USA.

Details can be found from here.

Conference presentation - 6th World Gene Convention 2015 -

Saisei-Mirai Medical Corporation’s Director as well as R-Mirai International Cancer Clinic’s Director, Professor Akiyama gave a presentation regarding ‘Combination of Cdc6 shRNA/p16 by Lentivirus Vector Inhibit Solid Tumor Growth In Vitro and In Vivo’ (Mixing of CDC6 shRNA and P16 due to Lentivirus Vector in ‘In Vitro’ and ‘In Vivo’, inhibit the growth of solid tumours.) at the 6th World Gene Convention 2015 organized by BITS at Qingdao in China on 14th November 2015.

6th World Gene Convention 2015 Official Website

New research papers published by Saisei Mirai in Anticancer Research available online.

New research papers on Oral Colostrum GcMAF for Chronic Fatigue Syndrome (CFS) and serious infection published in Anticancer Research journal.

Research paper 2015 Anticancer Res August 2015 35 (8) 4545-4549

Conference presentation - 10th International Congress for Medical Laser Applications, Germany -

13-JUN-2015 Clinical application of Second Generation GcMAF and oral GcMAF Dr Toshio Inui

ISLA website

Conference presentation - 9th International Congress for Medical Laser Applications, Germany -

29-JUN-2014 Indications for GcMAF for immunotherapy of cancers and chronic viral and bacterial infections (PDF) Dr Toshio Inui

Conference presentation - The 17th Annual Meeting of The Society of Biotherapeutic Approaches, Fukuoka University -

7-DEC-2013 Case Report: A Breast Cancer Patient Treated with GcMAF, Sonodynamic Therapy and Hormone Therapy (PDF) Dr Toshio Inui

New research papers published by Saisei Mirai in Anticancer Research available online.

New research papers on GcMAF and integrative cancer immunotherapy treatment written in collaboration with the University of Tokushima, Kanazawa University and Kobe University Graduate School of Medicine researchers and Saisei Mirai published in Anticancer Research journal.

Research Paper 2013 Degalactosylated/Desialylated Human Serum Containing GcMAF Induces Macrophage Phagocytic Activity and In Vivo Antitumor Activity (PDF) Anticancer Res July 2013 33 (7) 2881-2885

Research Paper 2013 Clinical Experience of Integrative Cancer Immunotherapy with GcMAF (PDF) Anticancer Res July 2013 33 (7) 2917-2919

Nature Outlook sponsored article

31-MAY-2012 GcMAF: Our next-generation immunotherapy.

Read article (PDF) , or here (PDF)

For more details on GcMAF see our GcMAF page.

Experiment report of Gc MAF stability assay

14-JUN-2012 Stability of GcMAF in Serum (PDF)

H Mukai, Y Uto. Department of Biological Science and Technology, The University of Tokushima.

The results show that 2nd Generation GcMAF is stable for 1 year at 4 °C, for 14 days at room temperature (around 20 °C), and for 7 days at 40 °C.

See Research and references for more details on experiments on macrophage phagocytic activity and stability of our GcMAF.

Collaborations with the University of Tokushima

We collaborate with GcMAF researchers at the University of Tokushima, Japan in the development of second generation GcMAF. See Research and references for published research papers on Gc-MAF in peer-reviewed scientific journals authored by the University of Tokushima researchers over the last decade. Our research on GcMAF is ongoing and papers are being prepared for publication in collaboration between the University of Tokushima and Saisei Mirai in the next few months.

Our research group: